Nucleotide signalling during inflammation

[1]  Hualiang Jiang,et al.  Agonist-bound structure of the human P2Y12 receptor , 2014, Nature.

[2]  Steven M. Moss,et al.  Structure of the human P2Y12 receptor in complex with an antithrombotic drug , 2014, Nature.

[3]  E. Clambey,et al.  CD73+ regulatory T cells contribute to adenosine‐mediated resolution of acute lung injury , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  T. Eckle,et al.  Attenuating myocardial ischemia by targeting A2B adenosine receptors. , 2013, Trends in molecular medicine.

[5]  T. Ferkol,et al.  Identifying the origins of cystic fibrosis lung disease. , 2013, The New England journal of medicine.

[6]  L. A. Alves,et al.  Is pannexin the pore associated with the P2X7 receptor? , 2013, Naunyn-Schmiedeberg's Archives of Pharmacology.

[7]  K. Ravid,et al.  Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  L. Ferris,et al.  Signaling through Purinergic Receptors for ATP Induces Human Cutaneous Innate and Adaptive Th17 Responses: Implications in the Pathogenesis of Psoriasis , 2013, The Journal of Immunology.

[9]  R. North,et al.  P2X Receptors as Drug Targets , 2013, Molecular Pharmacology.

[10]  T. Walsh,et al.  Mutation of the ATP-gated P2X2 receptor leads to progressive hearing loss and increased susceptibility to noise , 2013, Proceedings of the National Academy of Sciences.

[11]  L. Weiss,et al.  The split personality of regulatory T cells in HIV infection. , 2013, Blood.

[12]  M. Sitkovsky,et al.  Purinergic signaling during inflammation. , 2012, The New England journal of medicine.

[13]  Todd A. Durham,et al.  Long term effects of denufosol tetrasodium in patients with cystic fibrosis. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[14]  D. Ojcius,et al.  Role of extracellular nucleotides in the immune response against intracellular bacteria and protozoan parasites. , 2012, Microbes and infection.

[15]  Baljit S. Khakh,et al.  Neuromodulation by Extracellular ATP and P2X Receptors in the CNS , 2012, Neuron.

[16]  J. Balligand,et al.  Gene deletion of P2Y4 receptor lowers exercise capacity and reduces myocardial hypertrophy with swimming exercise. , 2012, American journal of physiology. Heart and circulatory physiology.

[17]  G. Burnstock,et al.  Purinergic Signaling in the Airways , 2012, Pharmacological Reviews.

[18]  C. Müller,et al.  Selective Activation of Adenosine A2A Receptors on Immune Cells by a CD73-Dependent Prodrug Suppresses Joint Inflammation in Experimental Rheumatoid Arthritis , 2012, Science Translational Medicine.

[19]  Jian Li,et al.  Roles of Purinergic Receptor P2Y, G Protein–Coupled 12 in the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[20]  R. Gangnon,et al.  Protection from asthma in a high-risk birth cohort by attenuated P2X(7) function. , 2012, The Journal of allergy and clinical immunology.

[21]  J. Stankova,et al.  P2Y6 Receptor Contributes to Neutrophil Recruitment to Inflamed Intestinal Mucosa by Increasing Cxc Chemokine Ligand 8 Expression in an AP‐1‐dependent Manner in Epithelial Cells , 2012, Inflammatory bowel diseases.

[22]  A. Nicke,et al.  Alternative Splicing of the N-Terminal Cytosolic and Transmembrane Domains of P2X7 Controls Gating of the Ion Channel by ADP-Ribosylation , 2012, PloS one.

[23]  N. Sträter,et al.  Cellular function and molecular structure of ecto-nucleotidases , 2012, Purinergic Signalling.

[24]  C. Borchers,et al.  Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch critical for myocardial adaptation to ischemia , 2012, Nature Medicine.

[25]  E. Lazarowski.  Vesicular and conductive mechanisms of nucleotide release , 2012, Purinergic Signalling.

[26]  K. Jacobson,et al.  G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions , 2012, Purinergic Signalling.

[27]  S. Colgan,et al.  Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. , 2012, Annual review of physiology.

[28]  J. Boyce,et al.  Gene‐by‐environment effect of house dust mite on purinergic receptor P2Y12 (P2RY12) and lung function in children with asthma , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[29]  Roger J. Thompson,et al.  Activation of neuronal P2X7 receptor-Pannexin-1 mediates death of enteric neurons during colitis , 2012, Nature Medicine.

[30]  H. Iba,et al.  Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors , 2012, Nature Communications.

[31]  T. Eckle,et al.  Ischemia and reperfusion—from mechanism to translation , 2011, Nature Medicine.

[32]  M. Idzko,et al.  Purinergic receptor type 6 contributes to airway inflammation and remodeling in experimental allergic airway inflammation. , 2011, American journal of respiratory and critical care medicine.

[33]  O. Delaneau,et al.  CD39/Adenosine Pathway Is Involved in AIDS Progression , 2011, PLoS pathogens.

[34]  Mingyao Liu,et al.  P2Y6 Agonist Uridine 5′-Diphosphate Promotes Host Defense against Bacterial Infection via Monocyte Chemoattractant Protein-1–Mediated Monocytes/Macrophages Recruitment , 2011, The Journal of Immunology.

[35]  E. Gendaszewska-Darmach,et al.  Nucleotide receptors as targets in the pharmacological enhancement of dermal wound healing , 2011, Purinergic Signalling.

[36]  M. Idzko,et al.  A potential role for P2X7R in allergic airway inflammation in mice and humans. , 2011, American journal of respiratory cell and molecular biology.

[37]  J. Freedman,et al.  Platelets and the immune continuum , 2011, Nature Reviews Immunology.

[38]  F. Di Virgilio,et al.  P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema. , 2011, American journal of respiratory cell and molecular biology.

[39]  W. Junger,et al.  Immune cell regulation by autocrine purinergic signalling , 2011, Nature Reviews Immunology.

[40]  M. Idzko,et al.  Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation. , 2011, Blood.

[41]  A. Ohta,et al.  A2B Adenosine Receptor Blockade Enhances Macrophage-Mediated Bacterial Phagocytosis and Improves Polymicrobial Sepsis Survival in Mice , 2011, The Journal of Immunology.

[42]  H. Kita,et al.  The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses , 2011, The Journal of Immunology.

[43]  F. Di Virgilio,et al.  The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation , 2010, Allergy.

[44]  M. Idzko,et al.  Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R , 2010, Nature Medicine.

[45]  M. Idzko,et al.  Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity , 2010, The Journal of experimental medicine.

[46]  P. Conley,et al.  Role of the P2Y12 Receptor in the Modulation of Murine Dendritic Cell Function by ADP , 2010, The Journal of Immunology.

[47]  Michael R. Elliott,et al.  Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis , 2010, Nature.

[48]  M. Smyth,et al.  Extracellular adenosine triphosphate and adenosine in cancer , 2010, Oncogene.

[49]  A. Schwab,et al.  Autocrine Purinergic Receptor Signaling Is Essential for Macrophage Chemotaxis , 2010, Science Signaling.

[50]  F. Di Virgilio,et al.  Purinergic Receptor Inhibition Prevents the Development of Smoke-Induced Lung Injury and Emphysema , 2010, The Journal of Immunology.

[51]  E. Vizi,et al.  A2B Adenosine Receptors Protect against Sepsis-Induced Mortality by Dampening Excessive Inflammation , 2010, The Journal of Immunology.

[52]  W. Junger,et al.  Purinergic Signaling: A Fundamental Mechanism in Neutrophil Activation , 2010, Science Signaling.

[53]  B. Fredholm,et al.  Purines – 80 years and very much alive , 2010, Acta physiologica.

[54]  T. K. Harden,et al.  Signalling and pharmacological properties of the P2Y14 receptor , 2010, Acta physiologica.

[55]  H. Kita,et al.  Human Eosinophils Recognize Endogenous Danger Signal Crystalline Uric Acid and Produce Proinflammatory Cytokines Mediated by Autocrine ATP , 2010, The Journal of Immunology.

[56]  S. Colgan,et al.  Signaling through the A2B Adenosine Receptor Dampens Endotoxin-Induced Acute Lung Injury , 2010, The Journal of Immunology.

[57]  F. Di Virgilio,et al.  Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[58]  P. Weller,et al.  Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules. , 2010, The Journal of allergy and clinical immunology.

[59]  P. Guns,et al.  P2Y receptors and atherosclerosis in apolipoprotein E‐deficient mice , 2010, British journal of pharmacology.

[60]  Geoffrey Burnstock,et al.  The double life of ATP. , 2009, Scientific American.

[61]  J. Muhlestein.  Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients , 2009, Thrombosis and Haemostasis.

[62]  S. Paruchuri,et al.  Leukotriene E4–induced pulmonary inflammation is mediated by the P2Y12 receptor , 2009, The Journal of experimental medicine.

[63]  J. Sévigny,et al.  Concomitant activation of P2Y2 and P2Y6 receptors on monocytes is required for TLR1/2‐induced neutrophil migration by regulating IL‐8 secretion , 2009, European journal of immunology.

[64]  J. Tschopp,et al.  Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors , 2009, Nature Medicine.

[65]  H. Friess,et al.  From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. , 2009, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Michael R. Elliott,et al.  Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance , 2009, Nature.

[67]  E. Gouaux,et al.  Crystal structure of the ATP-gated P2X4 ion channel in the closed state , 2009, Nature.

[68]  S. Colgan,et al.  Contribution of Adenosine A2B Receptors to Inflammatory Parameters of Experimental Colitis 1 , 2009, The Journal of Immunology.

[69]  T. Urano,et al.  Involvement of Platelet Activation by P2Y12 Receptor in the Development of Transplant Arteriosclerosis in Mice , 2009, Transplantation.

[70]  R. North,et al.  Signaling at purinergic P2X receptors. , 2009, Annual review of physiology.

[71]  H. Eltzschig,et al.  Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia. , 2009, Gastroenterology.

[72]  Masahiro Yamamoto,et al.  ATP drives lamina propria TH17 cell differentiation , 2008, Nature.

[73]  D. Candinas,et al.  Natural killer T cell dysfunction in CD39‐null mice protects against concanavalin A–induced hepatitis , 2008, Hepatology.

[74]  D. Kellerman,et al.  Denufosol: a review of studies with inhaled P2Y(2) agonists that led to Phase 3. , 2008, Pulmonary pharmacology & therapeutics.

[75]  K. E. El Kasmi,et al.  ATP Release from Vascular Endothelia Occurs Across Cx43 Hemichannels and Is Attenuated during Hypoxia , 2008, PloS one.

[76]  G. Burnstock.  Purinergic signalling and disorders of the central nervous system , 2008, Nature Reviews Drug Discovery.

[77]  H. Eltzschig,et al.  HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. , 2008, Blood.

[78]  S. Colgan,et al.  Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface. , 2008, Trends in cardiovascular medicine.

[79]  Djordje Grbic,et al.  Intestinal Inflammation Increases the Expression of the P2Y6 Receptor on Epithelial Cells and the Release of CXC Chemokine Ligand 8 by UDP1 , 2008, The Journal of Immunology.

[80]  W. Junger,et al.  A3 AND P2Y2 RECEPTORS CONTROL THE RECRUITMENT OF NEUTROPHILS TO THE LUNGS IN A MOUSE MODEL OF SEPSIS , 2007, Shock.

[81]  P. Insel,et al.  Mice lacking P2Y2 receptors have salt‐resistant hypertension and facilitated renal Na+ and water reabsorption , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[82]  C. Müller,et al.  CD39/Ectonucleoside Triphosphate Diphosphohydrolase 1 Provides Myocardial Protection During Cardiac Ischemia/Reperfusion Injury , 2007, Circulation.

[83]  L. LaVange,et al.  Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis. , 2007, American journal of respiratory and critical care medicine.

[84]  F. Di Virgilio,et al.  Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells , 2007, Nature Medicine.

[85]  N. Cianciotto,et al.  A bacterial ecto‐triphosphate diphosphohydrolase similar to human CD39 is essential for intracellular multiplication of Legionella pneumophila , 2007, Cellular microbiology.

[86]  Michel Mittelbronn,et al.  Identification of Ectonucleotidases CD39 and CD73 in Innate Protection during Acute Lung Injury1 , 2007, The Journal of Immunology.

[87]  V. Kuchroo,et al.  Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression , 2007, The Journal of experimental medicine.

[88]  K. Jacobson,et al.  UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis , 2007, Nature.

[89]  M. Idzko,et al.  Chemotactic activity of extracellular nucleotideson human immune cells. , 2007, Purinergic Signalling.

[90]  Linda Yip,et al.  ATP Release Guides Neutrophil Chemotaxis via P2Y2 and A3 Receptors , 2006, Science.

[91]  S. Colgan,et al.  ATP Release From Activated Neutrophils Occurs via Connexin 43 and Modulates Adenosine-Dependent Endothelial Cell Function , 2006, Circulation research.

[92]  S. Colgan,et al.  Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. , 2006, Blood.

[93]  Eric A. Barnard,et al.  International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy , 2006, Pharmacological Reviews.

[94]  B. Khakh,et al.  P2X receptors as cell-surface ATP sensors in health and disease , 2006, Nature.

[95]  F. Di Virgilio,et al.  Activation of human eosinophils via P2 receptors: novel findings and future perspectives , 2006, Journal of leukocyte biology.

[96]  R. Boucher,et al.  Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[97]  S. Mundell,et al.  P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. , 2005, Blood.

[98]  G. Burnstock,et al.  Impairment of the splenic immune system in P2X(2)/P2X(3) knockout mice. , 2005, Immunobiology.

[99]  M. Idzko,et al.  Characterization of the biological activities of uridine diphosphate in human dendritic cells: Influence on chemotaxis and CXCL8 release , 2004 .

[100]  Manfred Thiel,et al.  Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. , 2004, Annual review of immunology.

[101]  M. Idzko,et al.  Characterization of the biological activities of uridine diphosphate in human dendritic cells: Influence on chemotaxis and CXCL8 release. , 2004, Journal of cellular physiology.

[102]  J. Herbert,et al.  Gi‐dependent and ‐independent mechanisms downstream of the P2Y12 ADP‐receptor , 2004, Journal of thrombosis and haemostasis : JTH.

[103]  F. Di Virgilio,et al.  Stimulation of P2 purinergic receptors induces the release of eosinophil cationic protein and interleukin‐8 from human eosinophils , 2003, British journal of pharmacology.

[104]  Yuan Zhang,et al.  Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. , 2002, The Journal of clinical investigation.

[105]  A. Ohta,et al.  Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage , 2001, Nature.

[106]  F. Di Virgilio,et al.  P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production , 2000, FEBS letters.

[107]  Geoffrey Burnstock,et al.  Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X 3-deficient mice , 2000, Nature.

[108]  J. Brown,et al.  Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors , 2000, Nature.

[109]  E. Kawashima,et al.  The Cytolytic P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7) , 1996, Science.

[110]  F. Di Virgilio,et al.  The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. , 1995, The Journal of clinical investigation.

[111]  J. T. Turner,et al.  Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[112]  J. Wilting,et al.  Recent research on the biological activity of suramin. , 1993, Pharmacological reviews.

[113]  M. Knowles,et al.  Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. , 1991, The New England journal of medicine.

[114]  Patrizia,et al.  Purinergic P2Y2 Receptors Promote Neutrophil Infiltration and Hepatocyte Death in Mice with Acute Liver Injury , 2012 .

[115]  Ärztlicher Direktor,et al.  Endothelial Catabolism of Extracellular Adenosine during Hypoxia : Role of Surface Adenosine Deaminase and CD 26 , 2008 .

[116]  H. Friess,et al.  Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[117]  I. von Kügelgen.  Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. , 2006, Pharmacology & therapeutics.

[118]  F. Hawking.  Suramin: with special reference to onchocerciasis. , 1978, Advances in pharmacology and chemotherapy.